Prognostic Implication of the Absolute Lymphocyte to Absolute Monocyte Count Ratio in Patients With Classical Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine or Equivalent Regimens

Oncologist - United States
doi 10.1634/theoncologist.2015-0251
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Alphamed Press

Related search

The Ratio of the Absolute Lymphocyte Count to the Absolute Monocyte Count Is Associated With Prognosis in Hodgkin's Lymphoma: Correlation With Tumor-Associated Macrophages

Oncologist
Cancer ResearchMedicineOncology
2012English

HIV Status Does Not Influence Outcome in Patients With Classical Hodgkin Lymphoma Treated With Chemotherapy Using Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine in the Highly Active Antiretroviral Therapy Era

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2012English

Long-Term Follow Up of Patients With Human Immunodeficiency Virus Infection and Advanced Stage Hodgkin's Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine and Dacarbazine

Haematologica
Hematology
2013English

Prognostic Significance of Peripheral Blood Absolute Lymphocyte Count and Derived Neutrophil to Lymphocyte Ratio in Patients With Newly Diagnosed Extranodal Natural Killer/T-Cell Lymphoma

Cancer Management and Research
Oncology
2019English

A Pilot Trial of Adriamycin, Pembrolizumab, Vinblastine and Dacarbazine (Apvd) for Patients With Untreated Classical Hodgkin Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

The Prognostic Impact of Neutrophil-To-Lymphocyte Ratio, Lymphocyte-To-Monocyte Ratio, and Platelet-To-Lymphocyte Ratio in Patients With Advanced Colorectal Cancer Treated With First-Line Chemotherapy

Przeglad Gastroenterologiczny
Gastroenterology
2018English

Pre-Treatment Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio Are Prognostic of Progression in Early Stage Classical Hodgkin Lymphoma

British Journal of Haematology
Hematology
2017English

Nivolumab Plus Doxorubicin, Vinblastine and Dacarbazine for Newly Diagnosed Advanced-Stage Classical Hodgkin Lymphoma: Checkmate 205 Cohort D 2-Year Follow-Up

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Prognostic Value of Lymphocyte/Monocyte Ratio and Neutrophil/Lymphocyte Ratio at Diagnosis of Follicular Lymphoma.

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy